B. Metzler seel. Sohn & Co. AG Has $695,000 Stock Holdings in Ralliant Corporation $RAL

B. Metzler seel. Sohn & Co. AG lessened its holdings in shares of Ralliant Corporation (NYSE:RAL) by 51.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 13,656 shares of the company’s stock after selling 14,566 shares during the period. B. Metzler seel. Sohn & Co. AG’s holdings in Ralliant were worth $695,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in RAL. Cetera Investment Advisers bought a new position in Ralliant during the second quarter valued at about $700,000. Russell Investments Group Ltd. bought a new position in Ralliant during the second quarter valued at about $1,465,000. EverSource Wealth Advisors LLC bought a new position in Ralliant during the second quarter valued at about $39,000. First Trust Advisors LP bought a new position in Ralliant during the second quarter valued at about $2,013,000. Finally, Federated Hermes Inc. bought a new position in Ralliant during the second quarter valued at about $326,000.

Analyst Ratings Changes

RAL has been the topic of several research reports. Citigroup lowered their price target on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Weiss Ratings lowered Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Oppenheimer lowered their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Morgan Stanley restated an “overweight” rating and set a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Finally, Truist Financial lowered their price target on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $50.50.

Insider Buying and Selling

In other news, SVP Karen M. Bick sold 2,530 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the sale, the senior vice president directly owned 42,652 shares in the company, valued at approximately $1,983,318. This represents a 5.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Amir A. Kazmi acquired 2,545 shares of the stock in a transaction dated Friday, February 6th. The stock was bought at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the purchase, the senior vice president owned 39,699 shares in the company, valued at approximately $1,558,979.73. This trade represents a 6.85% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders purchased 8,145 shares of company stock worth $332,233.

Ralliant Trading Down 0.5%

RAL stock opened at $44.42 on Tuesday. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $57.02. The firm has a market cap of $4.97 billion and a P/E ratio of 22.66. The business’s 50 day moving average is $44.08 and its 200-day moving average is $46.87. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. The company’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS. Equities analysts anticipate that Ralliant Corporation will post 2.37 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Monday, March 9th. Ralliant’s dividend payout ratio is currently 10.20%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.